Delta Air Lines Analysts Boost Their Forecasts After Upbeat Earnings
Delta Air Lines, Inc. (NYSE: DAL) reported better-than-expected first-quarter earnings.
What’s Going On With Costco Stock Thursday?
Costco reported net sales of $23.48 billion for the retail month of March, up 9.4% on a year-over-year basis. Costco also announced its board approved a quarterly cash dividend increase from $1.02 per share to $1.16 per share, or $4.64 per share on an annualized basis
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Wall Street’s Most Accurate Analysts’ Views On 3 Health Care Stocks With Over 3% Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Citigroup Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
Citigroup Inc. (NYSE: C) is set to release earnings results for its first quarter before the opening bell on April 12, 2024.
Vaccine Player Vaxcyte Has Advantage Over Pfizer, Merck’s Pneumococcal Shots – Analyst Says
The global PCV market, valued at ~$8 billion annually, is poised for significant growth, estimated to reach ~$12 billion soon. Market dynamics are shifting towards adults, potentially doubling with the US discussing vaccination age reduction. Prevnar20 dominates with 97% market share in adults, but Vaxcyte's advanced conjugate capabilities present a competitive advantage.
Cartesian Therapeutics’ Rare Disease Candidate Shows Long Lasting Benefit Over Argenx’s Vyvgart, Analyst Initiates With Buy
Cartesian Therapeutics' autoimmune disease treatment with re-dosable mRNA CAR-Ts. Learn about Descartes-08, a promising anti-BCMA CAR-T therapy offering deeper, longer-lasting efficacy than current standards. Analysts project substantial market capture and peak sales potential.
Comcast’s Market Valuation Does Not Reflect Fair Value For It’s Significant Growth Portfolio: Analyst
Analyst reiterates Buy rating and $55 price target for Comcast Corp, with $1.2B in commitments for Olympics ads and strong brand partnerships, indicating undervaluation.
Block’s Growth Fueled by Cash App Expansion, Square Ecosystem Focus, Says Analyst
Mizuho analyst maintains Buy rating for Block and raises price target to $106, citing potential upside from Cash App and Square ecosystems.
Boeing Faces Delivery Downturn, But Analyst Sees Bright Spots In Orders
Stifel analyst lowered Boeing price target to $260 from $270 and maintained Buy rating. Lower deliveries reported.